The landscape of diabetic management is rapidly progressing, and cellular approaches are emerging as a particularly intriguing area of research. While standard treatments often focus on controlling blood glucose levels and addressing secondary issues, stem cell therapy holds the potential to target the underlying causes of Type-2 diabetes. Research